Suppr超能文献

可溶性物质对血型抗体的抑制作用。

Inhibition of blood group antibodies by soluble substances.

作者信息

Byrne Karen M, Mercado Chloe Marie C, Nnabue Thaddeus N, Paige Traci D, Flegel Willy A

机构信息

SBB Program Education Coordinator, National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, 10 Center Drive, Bethesda, MD.

Reference Technologist, American Red Cross, Pomona, CA.

出版信息

Immunohematology. 2019 Jan;35(1):19-22.

Abstract

The presence of multiple alloantibodies or an antibody to a highprevalance antigen in a patient sample can pose challenges in antibody identification. The pattern of reactivity seen on an antibody panel may show various strengths of reactivity by different methods of testing or same strength of reactivity at one or more phases of testing. To ensure proper identification, multiple investigative tools may be used. We review one of these methods-inhibition by soluble substances-which has become an expansion of our toolbox within the past 10 years. Alloantibodies can be inhibited using specific soluble substances. These soluble substances occur naturally in various fluids or can be manufactured. When a patient sample contains multiple antibodies, clinically significant or not, inhibition of one may help determine specificities of others. Specific inhibition of a particular antibody will also help to confirm its presence.

摘要

患者样本中存在多种同种抗体或针对高流行抗原的抗体,可能会给抗体鉴定带来挑战。在抗体筛查细胞上观察到的反应模式可能因不同的检测方法而显示出不同强度的反应,或者在一个或多个检测阶段显示相同强度的反应。为确保正确鉴定,可能会使用多种调查工具。我们回顾其中一种方法——可溶性物质抑制法,在过去10年里,它已成为我们工具库的扩展内容。同种抗体可以使用特定的可溶性物质进行抑制。这些可溶性物质天然存在于各种体液中,也可以人工制造。当患者样本含有多种抗体时,无论是否具有临床意义,抑制其中一种抗体可能有助于确定其他抗体的特异性。对特定抗体的特异性抑制也将有助于确认其存在。

相似文献

1
5
Comparative sensitivity of solid phase versus PEG enhancement assays for detection and identification of RBC antibodies.
Transfus Apher Sci. 2006 Aug;35(1):19-23. doi: 10.1016/j.transci.2006.02.002. Epub 2006 Aug 14.
6
Microcomputer interpretation of red blood cell panels.
Am J Clin Pathol. 1985 Apr;83(4):469-73. doi: 10.1093/ajcp/83.4.469.
8
Neutralization of Knops system antibodies using soluble complement receptor 1.
Transfusion. 1996 Jun;36(6):517-20. doi: 10.1046/j.1537-2995.1996.36696269510.x.
9
A platelet monoclonal antibody inhibition assay for detection of glycoprotein IIb/IIIa-related platelet alloantibodies.
J Immunol Methods. 1995 Aug 18;184(2):153-62. doi: 10.1016/0022-1759(95)00083-m.
10
Hemagglutination inhibition of Cromer blood group antibodies with soluble recombinant decay-accelerating factor.
Transfusion. 1998 Apr;38(4):332-6. doi: 10.1046/j.1537-2995.1998.38498257370.x.

引用本文的文献

1
Application of Saliva Inhibition to Detect Underlying Alloantibodies in Bombay Blood Group.
Transfus Med Hemother. 2021 Dec 10;49(3):180-184. doi: 10.1159/000520712. eCollection 2022 Jun.
2
Identification and Quantification of Anti-Gp.Mur Antibodies in Human Serum Using an Insect-Cell-Based System.
Diagnostics (Basel). 2021 May 27;11(6):966. doi: 10.3390/diagnostics11060966.
3
When recombinant proteins can replace rare red cells in immunohematology workups.
Transfusion. 2021 Jul;61(7):2204-2212. doi: 10.1111/trf.16507. Epub 2021 May 31.
4
SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
Transfusion. 2021 Jan;61(1):246-254. doi: 10.1111/trf.16152. Epub 2020 Oct 24.
6
An update on the Scianna blood group system.
Immunohematology. 2019 Jun;35(2):48-50.

本文引用的文献

1
Can anti-A cause hemolysis?
Transfusion. 2018 Dec;58(12):3036-3037. doi: 10.1111/trf.14996.
2
Monoclonal anti-CD47 interference in red cell and platelet testing.
Transfusion. 2019 Feb;59(2):730-737. doi: 10.1111/trf.15033. Epub 2018 Dec 5.
3
CD47 is a novel potent immunotherapy target in human malignancies: current studies and future promises.
Future Oncol. 2018 Sep;14(21):2179-2188. doi: 10.2217/fon-2018-0035. Epub 2018 Apr 18.
4
Molecular immunohaematology round table discussions at the AABB Annual Meeting, Orlando 2016.
Blood Transfus. 2018 Sep;16(5):447-456. doi: 10.2450/2018.0260-17. Epub 2018 Feb 14.
5
CD38 Monoclonal Antibody Therapies for Multiple Myeloma.
Clin Lymphoma Myeloma Leuk. 2015 Nov;15(11):635-45. doi: 10.1016/j.clml.2015.07.642. Epub 2015 Aug 5.
6
When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy.
Transfusion. 2015 Jun;55(6 Pt 2):1555-62. doi: 10.1111/trf.13150. Epub 2015 May 18.
8
A new blood group antigen is defined by anti-CD59, detected in a CD59-deficient patient.
Transfusion. 2014 Jul;54(7):1817-22. doi: 10.1111/trf.12531. Epub 2014 Jan 3.
9
Organization and management of an accredited specialist in blood bank (SBB) technology program.
Transfusion. 2010 Jul;50(7 Pt 2):1612-7. doi: 10.1111/j.1537-2995.2010.02737.x.
10
The human ABO blood group substances.
Experientia. 1947 Jul 15;3(7):257-67. doi: 10.1007/BF02164164.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验